Cardiovascular medication use following percutaneous coronary intervention: the Australian experience. [electronic resource]
- Cardiovascular therapeutics Apr 2014
- 47-51 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1755-5922
10.1111/1755-5922.12060 doi
Aged Cardiovascular Agents--classification Coronary Artery Disease--diagnosis Drug Utilization Review Female Guideline Adherence Humans Male Percutaneous Coronary Intervention--adverse effects Practice Guidelines as Topic Practice Patterns, Physicians'--trends Prospective Studies Registries Risk Factors Secondary Prevention--methods Time Factors Treatment Outcome Victoria